口服益生菌辅助治疗结肠癌的研究进展  

Progress of oral probiotics in adjuvant treatment of colon cancer

作　　者：单贵钢 郭建昇[2] Shan Guigang;Guo Jiansheng(Graduate School,Shanxi Medical University,Taiyuan 030001,China;Department of General Surgery,the First Hospital of Shanxi Medical University,Taiyuan 030001,China)

机构地区：[1]山西医科大学研究生学院,太原030001 [2]山西医科大学第一医院普外科,太原030001

出　　处：《肿瘤研究与临床》2021年第12期881-884,共4页Cancer Research and Clinic

摘　　要：近年来结肠癌的发病率逐年上升,但结肠癌的发病机制仍未明确。随着对结肠癌发病原因的研究不断深入,发现肠道菌群与结肠癌的发生、发展有密切的关系。根据研究成果在临床上尝试使用益生菌制剂调节肠道菌群辅助治疗结肠癌同样也取得了一定的效果,值得在临床上推广。In recent years,the incidence of colon cancer has increased year by year,but the pathogenesis of colon cancer is still unclear.With the in-depth research on the cause of colon cancer,people have found that there's a close relationship between intestinal flora and the occurrence and development of colon cancer.According to the research results,clinical attempts have been made to use probiotics for colon cancer patients to regulate the intestinal flora,thereby assisting in the treatment of colon cancer,and these attempts have achieved certain results and are worthy of clinical promotion.

关 键 词：结肠肿瘤 益生菌 肠道菌群 

分 类 号：R735.35[医药卫生—肿瘤]